- Home
- ON vs ROIV Comparison
ON vs ROIV Comparison
Compare ON & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ON | ROIV |
|---|---|---|
| Founded | 1992 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.1B | 20.7B |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ON | ROIV |
|---|---|---|
| Price | $59.04 | $29.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 25 | 8 |
| Target Price | ★ $64.46 | $27.56 |
| AVG Volume (30 Days) | ★ 7.9M | 5.9M |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $5,878,300,000.00 | $29,053,000.00 |
| Revenue This Year | $8.02 | N/A |
| Revenue Next Year | $10.15 | $385.85 |
| P/E Ratio | $196.86 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $31.04 | $8.73 |
| 52 Week High | $73.76 | $30.03 |
Technical Indicators
Market Signals| Indicator | ON | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 37.29 | 66.48 |
| Support Level | $52.58 | $20.46 |
| Resistance Level | $63.63 | N/A |
| Average True Range (ATR) | 2.61 | 0.96 |
| MACD | -1.59 | -0.01 |
| Stochastic Oscillator | 19.65 | 84.62 |
Price Performance
Historical ComparisonAbout ON ON Semiconductor Corporation
Onsemi is a supplier of power semiconductors and sensors focused on the automotive and industrial markets. Onsemi is the second-largest power chipmaker in the world and the largest supplier of image sensors to the automotive market. While the firm used to be highly vertically integrated, it now pursues a hybrid manufacturing strategy for flexible capacity. Onsemi is pivoting to focus on emerging applications like electric vehicles, autonomous vehicles, industrial automation, and renewable energy.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.